SEC Form 4 · accession 0001140361-16-069010
Emergent BioSolutions Inc. · EBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George A Joulwan
Director
Period of report
Jun 6, 2016
Accepted (ET)
Jun 7, 2016 · 9:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jun 6, 2016 | S | 4,700 | $44.12 | D | 20,785 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Consists of vested restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended.
- F2The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.10 to $44.15.